Loading clinical trials...

A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDNANCT02991430

A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

This study will assess the efficacy of a neuromodulation device for the treatment of episodic migraine headache.

Lead sponsor: Scion NeuroStim•8 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGNA

Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Among Minorities

NCT05701085 · Educational Intervention, Minorities

RECRUITINGNA

Study of Self-Help and Support Services for Student Mental Health in Tertiary Institutions

NCT06623682 · Mental Health, Mental Well-being, and more

RECRUITINGNA

Dyadic Mindfulness for People With Parkinson's Disease and Their Caregivers

NCT06821230 · Mindfulness, Caregivers, and more

RECRUITINGNA

Sustaining Physical Activity After Cancer Exercise Sessions

NCT06359210 · Exercise Oncology, Physical Activity Behavior, and more

RECRUITINGNA

ELEVATE High-Risk PCI Pivotal Study

NCT07001332 · High-Risk Percutaneous Coronary Intervention (High-risk PCI)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 19, 2019Terms

Trial snapshot

StatusTERMINATED

PhaseNA

Enrollment45

Start dateJun 2017

Last updatedJun 19, 2019

Condition

Intervention

Locations shown

Mayo Clinic

Scottsdale, Arizona

Neurology Research Institute

West Palm Beach, Florida

Diamond Headache Clinic

Chicago, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 19, 2019Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Patient Navigator PRE-ACT Educational Intervention to Promote Decision Making Among Minorities

Study of Self-Help and Support Services for Student Mental Health in Tertiary Institutions

Dyadic Mindfulness for People With Parkinson's Disease and Their Caregivers

Sustaining Physical Activity After Cancer Exercise Sessions

ELEVATE High-Risk PCI Pivotal Study

Trial snapshot

Condition

Locations shown

For caregivers